ARTICLES BY JOHN CARLOS DIAZ

  • Combatting The Professional Patient Problem In Clinical Trials
    Combatting The Professional Patient Problem In Clinical Trials

    Clinical research patients are compensated for their participation in clinical trials. The compensation is based on the burden the trial imposes on the patient and is vetted through an institutional review board, so patients are not overly influenced by financial gain to enroll.

John Carlos Diaz

John Carlos Diaz

John Carlos Diaz has been in the pharmaceutical industry for 18 years, with ranging operational experiences from preclinical drug metabolism and pharmacokinetics (DPMK), clinical pharmacology/Phase 1, adult/pediatric, global Phase 2–4, and investigator-initiated trials. Currently, John and GeoSera are using their experienced clinical research network to benefit sponsor companies, clinical research sites, clinical trial service providers, and CROs. You can reach him at johndiaz@geosera.com or 484-568-3952.